Phase 2 trial of MNK-1411

Trial Profile

Phase 2 trial of MNK-1411

Phase of Trial: Phase II

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Tetracosactide (Primary)
  • Indications Duchenne muscular dystrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jul 2017 According to a Mallinckrodt plc media release, this trial is expected to initiate in late 2017.
    • 14 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top